Background: Toxic megacolon is a life-threatening complication of ulcerative colitis (UC) characterized by systemic toxicity, loss of blood per rectum and severe pain. Pain management is challenging in these patients because nonsteroidal anti-inflammatory drugs may exacerbate bleeding and opioids are contraindicated because they adversely affect bowel peristalsis causing an increased risk of colonic perforation.

Methods: We describe three episodes of fulminating UC in two children in whom ketamine analgesia was used. Our protocol for a low-dose continuous ketamine infusion with either nurse-controlled analgesia (NCA) or patient-controlled analgesia (PCA) bolus administration is presented and a review of the literature regarding the use of ketamine analgesia in children is discussed.

Results: Low-dose ketamine N/PCA with a continuous background infusion provided satisfactory analgesia and none of our children reported adverse effects.

Conclusions: We have demonstrated the safe and effective use of ketamine analgesia in children with toxic megacolon, a condition in which the child is in severe pain and morphine is contraindicated.

References

1 Leichtner AM, Higuchi L. Ulcerative colitis. In: WA Walker, O Goulet, RA Kleinman, PM Sherman, BL Shneider, IR Sanderson, eds. Pediatric Gastrointestinal Disease. New York: B C Decker Inc., 2005: 825–849.
Google Scholar
2 British Society of Gastroenterology. Guidelines for the Management of Inflammatory Bowel Disease; 2004. Available at: http://www.bsg.org.uk/clinical_prac/guidelines.htm (accessed July 12, 2005).
Google Scholar
3 Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995; 62: 259–274.
10.1016/0304-3959(95)00073-2
CAS PubMed Web of Science® Google Scholar
4 Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 293–299.
10.1016/0304-3959(91)90100-C
CAS PubMed Web of Science® Google Scholar
5 Mao J, Price DD, Mayer DJ. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995; 61: 353–364.
10.1016/0304-3959(95)00022-K
CAS PubMed Web of Science® Google Scholar
6 Stubhaug A, Breivik H, Eide PK et al. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiol Scand 1997; 41: 1124–1132.
10.1111/j.1399-6576.1997.tb04854.x
CAS PubMed Web of Science® Google Scholar
7 Weinbroum AA, Gorodezky A, Niv D et al. Dextromethorphan attenuation of postoperative pain and primary and secondary thermal hyperalgesia. Can J Anaesth 2001; 48: 167–174.
10.1007/BF03019730
CAS PubMed Web of Science® Google Scholar
8 Dix P, Martindale S, Stoddart PA. Double-blind randomized placebo-controlled trial of the effect of ketamine on postoperative morphine consumption in children following appendicectomy. Paediatr Anaesth 2003; 13: 422–426.
10.1046/j.1460-9592.2003.01090.x
CAS PubMed Web of Science® Google Scholar
9 Elhakim M, Khalafallah Z, El Fattah HA et al. Ketamine reduces swallowing-evoked pain after paediatric tonsillectomy. Acta Anaesthesiol Scand 2003; 47: 604–609.
10.1034/j.1399-6576.2003.00111.x
CAS PubMed Web of Science® Google Scholar
10 O'Flaherty JE, Lin CX. Does ketamine or magnesium affect posttonsillectomy pain in children? Paediatr Anaesth 2003; 13: 413–421.
10.1046/j.1460-9592.2003.01049.x
PubMed Web of Science® Google Scholar
11 Klepstad P, Borchgrevink P, Hval B et al. Long-term treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor. J Pediatr Hematol Oncol 2001; 23: 616–619.
10.1097/00043426-200112000-00013
CAS PubMed Web of Science® Google Scholar
12 Tsui BC, Davies D, Desai S et al. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma. J Pediatr Hematol Oncol 2004; 26: 678–680.
10.1097/01.mph.0000140656.96085.2c
PubMed Web of Science® Google Scholar
13 Kochs E, Scharein E, Mollenberg O et al. Analgesic efficacy of low-dose ketamine. Somatosensory-evoked responses in relation to subjective pain ratings. Anesthesiology 1996; 85: 304–314.
10.1097/00000542-199608000-00012
CAS PubMed Web of Science® Google Scholar
14 Krystal JH, Karper LP, Seibyl JP et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994; 51: 199–214.
10.1001/archpsyc.1994.03950030035004
CAS PubMed Web of Science® Google Scholar
15 Subramaniam K, Subramaniam B, Steinbrook RA. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 2004; 99: 482–495.
10.1213/01.ANE.0000118109.12855.07
CAS PubMed Web of Science® Google Scholar
16 Elia N, Tramer MR. Ketamine and postoperative pain–a quantitative systematic review of randomised trials. Pain 2005; 113: 61–70.
10.1016/j.pain.2004.09.036
CAS PubMed Web of Science® Google Scholar
17 Bell R, Eccleston C, Kalso E. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 2003; CD003351.
10.1002/14651858.CD003351
PubMed Google Scholar

Citing Literature

Volume16, Issue11

November 2006

Pages 1148-1152

Pain management in fulminating ulcerative colitis

Summary

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Pain management in fulminating ulcerative colitis

Summary

References

Citing Literature

References

Related

Information